Eva-Maria Hempe, Executive Director Healthcare and Life Sciences EMEA (Europe, Middle East and Africa) at NVIDIA, shared a post on LinkedIn:
“We (also) write Nature Papers – If you still think NVIDIA is just GPUs, think again.
Very proud of my team mates David Ruau and Ben Griffiths who had the perspective piece they wrote together with our friends at AstraZeneca, Memorial Sloan Kettering Cancer Center and SOPHiA GENETICS accepted at Nature AI!
The authors argue that multimodal AI can help clinicians, by integrating clinical, imaging, pathology, molecular and real-world data, make more timely, evidence-based decisions and strengthen research and healthcare systems. The article outlines technical foundations, guardrails (privacy, bias mitigation, evaluation), and a pragmatic roadmap from pilots to clinical impact.
Whether you are in academia, industry, and healthcare – we hope you build on this blueprint to accelerate better care for patients worldwide!”
Title: The AI revolution: how multimodal intelligence will reshape the oncology ecosystem
Authors: David Dellamonica, David Ruau, Ben Griffiths, Greg Rossi, Bob T. Li, Pedram Razavi, Thomas Di Maio, Tristan Gonzalez, Amanda Remorino, Jorge S. Reis-Filho, Philippe Menu, Thorsten Gutjahr, Adrien Moucquot, Tom Diethe, Hassan Naqvi, Ross Muken, Pablo Azcue
Read the Full Article on npj Artificial Intelligence
More posts featuring NVIDIA.